Jeffrey Calabrese - Jul 1, 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
Vice President of Finance
Signature
/s/ John W. LaRocca, Attorney-in-Fact for Jeffrey Calabrese
Stock symbol
AERI
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4
Date filed
7/6/2022, 04:44 PM
Previous filing
Nov 8, 2021
Next filing
Aug 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Award $0 +11.3K +140.62% $0.00 19.3K Jul 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +20.8K $0.00 20.8K Jul 1, 2022 Common Stock 20.8K $8.36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of July 1, 2022.
F2 This Option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of July 1, 2022.